Zhejiang Shangyao Jiuzhou Biopharmaceutical

Zhejiang Shangyao Jiuzhou Biopharmaceutical is a strategic joint venture between Shanghai Pharmaceuticals Holding and Zhejiang Jiuzhou Pharmaceutical, established in 2021. Headquartered in Hangzhou, China, the company operates as a high-end Contract Development and Manufacturing Organization (CDMO) specializing in both innovative chemical drugs and biopharmaceuticals. The partnership combines Shanghai Pharma's extensive commercial network and supply chain with Jiuzhou Pharma's deep expertise in API synthesis and process chemistry. The company's state-of-the-art facilities are designed to meet global regulatory standards, including GMP requirements for the US, EU, and China. Its service offerings span from early-stage process optimization to large-scale commercial manufacturing of finished dosage forms. By focusing on high-quality production, the company aims to serve as a critical link in the global pharmaceutical value chain.